Schedule 13G ownership disclosure

Spark Therapeutics, Inc.

Security class unavailable · CUSIP: 84652J103

Event date: 2018-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,497,788
Percent of class
4.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-18-000364
Form type
SC 13G/A
Filer
FEDERATED HERMES, INC.
CIK
CIK 1056288
Filed
Mar 09, 2018
Reporting period
Feb 28, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub